CD38 and colon adenocarcinoma: To analyze whether the anti-mCD38/anti-mPD-1 combination is also effective in other CD38+ tumors, we tested the combination of anti-mPD-1 and anti-mCD38 treatment in mice with established MC38 colon adenocarcinoma tumors, which also express CD38 (Figure 5A).